These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9797517

  • 21. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K.
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [Abstract] [Full Text] [Related]

  • 22. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE, Donati F, Bevan DR.
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [Abstract] [Full Text] [Related]

  • 23. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J, Ostergaard D, Skovgaard LT, Viby-Mogensen J.
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [Abstract] [Full Text] [Related]

  • 24. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H, Lindholm P, Petersen HS, Severinsen IK.
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [Abstract] [Full Text] [Related]

  • 25. Cisatracurium neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans.
    Kim KS, Chung CW, Shin WJ.
    Br J Anaesth; 1999 Sep; 83(3):483-4. PubMed ID: 10655927
    [Abstract] [Full Text] [Related]

  • 26. Timing of reversal with respect to three nerve stimulator end-points from cisatracurium-induced neuromuscular block.
    Song IA, Seo KS, Oh AY, No HJ, Hwang JW, Jeon YT, Park SH, Do SH.
    Anaesthesia; 2015 Jul; 70(7):797-802. PubMed ID: 26580249
    [Abstract] [Full Text] [Related]

  • 27. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia.
    Wulf H, Kahl M, Ledowski T.
    Br J Anaesth; 1998 Mar; 80(3):308-12. PubMed ID: 9623429
    [Abstract] [Full Text] [Related]

  • 28. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG, Lewis B, Bedocs NM.
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [Abstract] [Full Text] [Related]

  • 29. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial.
    Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C.
    Eur J Anaesthesiol; 2013 Oct; 30(10):594-8. PubMed ID: 23803594
    [Abstract] [Full Text] [Related]

  • 30. [Cisatricurium in the orbicularis oculi muscle. Comparisn of the neuromuscular action of cisatracurium and atracurium in the orbicularis oculi muscle and the adductor pollicis muscle].
    de Rossi L, Fritz H, Kröber L, Klein U.
    Anaesthesist; 1999 Sep; 48(9):602-6. PubMed ID: 10525592
    [Abstract] [Full Text] [Related]

  • 31. Factors predicting atracurium reversal time.
    Kirkegaard-Nielsen H, Severinsen IK, Pedersen HS, Lindholm P.
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
    [Abstract] [Full Text] [Related]

  • 32. Early reversal of rapacuronium with neostigmine.
    Purdy R, Bevan DR, Donati F, Lichtor JL.
    Anesthesiology; 1999 Jul; 91(1):51-7. PubMed ID: 10422928
    [Abstract] [Full Text] [Related]

  • 33. Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease.
    Soltész S, Mencke T, Mey C, Röhrig S, Diefenbach C, Molter GP.
    Br J Anaesth; 2008 Jun; 100(6):798-802. PubMed ID: 18400809
    [Abstract] [Full Text] [Related]

  • 34. Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol.
    Reid JE, Breslin DS, Mirakhur RK, Hayes AH.
    Can J Anaesth; 2001 Apr; 48(4):351-5. PubMed ID: 11339776
    [Abstract] [Full Text] [Related]

  • 35. The effect of ondansetron on atracurium-induced neuromuscular blockade.
    Lien CA, Gadalla F, Kudlak TT, Embree PB, Sharp GJ, Savarese JJ.
    J Clin Anesth; 1993 Apr; 5(5):399-403. PubMed ID: 8217176
    [Abstract] [Full Text] [Related]

  • 36. The safety and efficacy of cisatracurium 0.15 mg.kg(-1) during nitrous oxide-opioid anaesthesia in infants and children.
    Taivainen T, Meakin GH, Meretoja OA, Wirtavuori K, Perkins RJ, Murphy AK, Fisher GR, Waiter MR.
    Anaesthesia; 2000 Nov; 55(11):1047-51. PubMed ID: 11069329
    [Abstract] [Full Text] [Related]

  • 37. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ.
    Anesthesiology; 1995 May; 82(5):1139-45. PubMed ID: 7741288
    [Abstract] [Full Text] [Related]

  • 38. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: A double-blind, randomised study.
    Preault A, Capron F, Chantereau C, Donati F, Dimet J.
    Anaesth Crit Care Pain Med; 2016 Aug; 35(4):269-73. PubMed ID: 27131419
    [Abstract] [Full Text] [Related]

  • 39. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M, Vilardi V, Fierro G, Rosa G, Pelaia P, Gasparetto A.
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [Abstract] [Full Text] [Related]

  • 40. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M, Abdulatif M, al-Ghamdi A.
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.